S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
Log in

LON:SKIN - Integumen Share Price, Forecast & News

GBX 1.52
-0.02 (-1.29 %)
(As of 12/12/2019 04:00 PM ET)
Today's Range
1.50
Now: GBX 1.53
1.54
50-Day Range
1.55
MA: GBX 1.74
1.92
52-Week Range
0.44
Now: GBX 1.53
2.58
Volume3.06 million shs
Average Volume41,864 shs
Market Capitalization£14.96 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Integumen Plc, a personal health care company, develops and commercializes a range of products for oral, skin, and wound care markets. The company develops TS1, a disposable tongue vacuum cleaner for professional use in the dental surgery, a tongue gel, and a handle, which turns the tongue vacuum cleaner into a tongue scraper for home use. It also offers Labskin, a 3-dimensional human skin equivalent model for basic and applied skin research, pre-clinical screening, microbial testing, and efficacy studies of personal care products. In addition, the company provides a range of cosmetic skincare products under the Stoer brand; consumer and professional cosmeceutical products under the Visible Youth brand for anti-ageing; and Clarogel, an over-the-counter cosmetic product for the treatment of blemishes. In addition, it offers Wound pHase, a diagnostic tool, which is used in the acidity/alkalinity of the wound; and hydrogel as a dressing for use in the treatment of burns. The company was incorporated in 2016 and is headquartered in Dalkey, Ireland.

Industry, Sector and Symbol

Industry Household & Personal Products
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+353-1-5373269

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£567,000.00
Cash FlowGBX 0.09 per share
Book ValueGBX 0.50 per share

Profitability

Miscellaneous

Employees9
Market Cap£14.96 million
Next Earnings DateN/A
OptionableNot Optionable

Receive SKIN News and Ratings via Email

Sign-up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.


Integumen (LON:SKIN) Frequently Asked Questions

What is Integumen's stock symbol?

Integumen trades on the London Stock Exchange (LON) under the ticker symbol "SKIN."

Has Integumen been receiving favorable news coverage?

News headlines about SKIN stock have trended extremely negative this week, InfoTrie reports. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Integumen earned a coverage optimism score of -4.1 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the company's share price in the next few days. View News Stories for Integumen.

Who are some of Integumen's key competitors?

What other stocks do shareholders of Integumen own?

Who are Integumen's key executives?

Integumen's management team includes the folowing people:
  • Mr. Christopher Bell, CFO, Company Sec. & Exec. Director
  • Mr. Donald Nicholson, Exec. Director (Age 61)
  • Mr. Gerard James Brandon, CEO & Director (Age 57)
  • Mr. Camillus Gerard Glover, COO & Director (Age 58)
  • Alex Chapman, Head of Labskin Operations

How do I buy shares of Integumen?

Shares of SKIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Integumen's stock price today?

One share of SKIN stock can currently be purchased for approximately GBX 1.53.

How big of a company is Integumen?

Integumen has a market capitalization of £14.96 million and generates £567,000.00 in revenue each year. Integumen employs 9 workers across the globe.View Additional Information About Integumen.

What is Integumen's official website?

The official website for Integumen is http://www.integumen.co.uk/.

How can I contact Integumen?

Integumen's mailing address is Dalkey, 19 Railway Road, DUBLIN, YO41 1LZ, Ireland. The company can be reached via phone at +353-1-5373269.


MarketBeat Community Rating for Integumen (LON SKIN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  61
MarketBeat's community ratings are surveys of what our community members think about Integumen and other stocks. Vote "Outperform" if you believe SKIN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SKIN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel